Search results
Three SLE medications were recently approved by the Food and Drug Administration: belimumab (for active SLE in 2011 and for lupus nephritis in 2020), voclosporin (for lupus nephritis), and anifrolumab (for active SLE).
7 maj 2024 · Three SLE medications were recently approved by the Food and Drug Administration: belimumab (for active SLE in 2011 and for lupus nephritis in 2020), voclosporin (for lupus nephritis), and anifrolumab (for active SLE).
Drug-induced lupus erythematosus (DILE) is best defined as an adverse reaction of treatment with a certain drug taken continuously over time, inducing lupus-like symptoms.
Nearly all patients with lupus should be treated with hydroxychloroquine, a medication that decreases inflammation, improves lupus symptoms, and reduces risk of death. Patients with moderate to severe lupus may receive steroids and other immunosuppressive medications, such as azathioprine, mycophenolate mofetil, methotrexate, tacrolimus, and ...
15 lip 2018 · This paper presents the case of a 39 year old patient diagnosed with systemic lupus erythematosus (SLE) with class IV lupus nephropathy (LN) who developed numerous complications due to the pathogenic side effects: diabetes, amenorrhea, recurrent infections, and depression.
Treatment should be with the goal of remission or low-disease activity and when possible, minimising damage attributable to medication side-effects. Specific guidelines exist for renal disease (although the therapies are slow and partially effective most of the time).
5 gru 2020 · Minor side effects include gastric intolerance; rash; hyperpigmentation of the skin, nails and gums and aquagenic pruritus . Cardiotoxicity, usually presenting as congestive heart failure and/or syncope, can rarely occur after prolonged therapy .
